Listed

Tempest Therapeutics, Inc.: Form 10-Q for the period ended Jun 30, 2022

Filed with the SEC on Aug 15, 2022 and accepted by EDGAR at Aug 15, 2022, 08:10 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2022-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Operating income3 months2022-04-01 to 2022-06-30−$8.8mus-gaap:OperatingIncomeLoss
Operating income6 months2022-01-01 to 2022-06-30−$16.9mus-gaap:OperatingIncomeLoss
Interest expense3 months2022-04-01 to 2022-06-30$464.0kus-gaap:InterestExpense
Interest expense6 months2022-01-01 to 2022-06-30$797.0kus-gaap:InterestExpense
Income tax3 months2022-04-01 to 2022-06-30$0us-gaap:IncomeTaxExpenseBenefit
Income tax6 months2022-01-01 to 2022-06-30$0us-gaap:IncomeTaxExpenseBenefit
Net income3 months2022-04-01 to 2022-06-30−$9.2mus-gaap:NetIncomeLoss
Net income6 months2022-01-01 to 2022-06-30−$17.7mus-gaap:NetIncomeLoss
Diluted EPS3 months2022-04-01 to 2022-06-30−$0.79us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2022-01-01 to 2022-06-30−$1.88us-gaap:EarningsPerShareDiluted
Basic EPS3 months2022-04-01 to 2022-06-30−$0.79us-gaap:EarningsPerShareBasic
Basic EPS6 months2022-01-01 to 2022-06-30−$1.88us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2022-04-01 to 2022-06-3011,573,432 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2022-01-01 to 2022-06-309,382,515 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2022-01-01 to 2022-06-30−$15.5mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2022-01-01 to 2022-06-30$98.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2022-06-30$51.6mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2022-06-30$68.3mus-gaap:AssetsCurrent
Total assetsAt period end2022-06-30$71.4mus-gaap:Assets
Current liabilitiesAt period end2022-06-30$22.4mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2022-06-30$36.4mus-gaap:Liabilities
Long-term debtAt period end2022-06-30$13.3mus-gaap:LongTermDebtNoncurrent
Shareholders' equityAt period end2022-06-30$34.9mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001628280-22-022788. Last ingested by Listed: Nov 15, 2026, 00:20 ET. Listed shows no prices and gives no investment advice.